Abstract
INTRODUCTION
The initial event in acute aortic dissection is an intimal tear that penetrates the aortic media. The aortic media consists of vascular smooth muscle cells (VSMCs) and surrounding extracellular matrix (ECM), including collagen, elastin, laminin, gelatin and proteoglycans. Dysregulation of TGF-b signalling contributes to aneurysm progression by affecting ECM homeostasis in patients with a connective tissue disorder such as Marfan syndrome or Loeys-Dietz syndrome [1, 2] . Enhanced caspase activity may play roles in early aneurysm development [3] . In addition, loss-offunction mutations of genes involved in the functional regulation of VSMCs, such as MYH11 (encoding a smooth muscle-specific myosin isoform) [4] and ACTA2 (encoding a smooth-muscle actin) [5] , reportedly cause hereditary thoracic aortic diseases without specific physical features (non-syndromic thoracic aortic aneurysm and dissection) [2] . Medial degeneration is now thought to be a fundamental histologic change that predisposes to aortic dissection. Although physical [6] and physiological [7] factors may play roles in intimal tear formation, the mechanisms underlying medial degeneration in patients with non-hereditary thoracic aortic disease, such as that in the majority of patients with aortic dissection, are poorly understood.
Gene expression profiling achieved through microarray technology is a powerful tool that can be used to investigate underlying pathological mechanisms and responses to new treatments, and it is gaining widespread acceptance in the field of cardiovascular medicine [8] [9] [10] [11] [12] . By array analysis, the expression profiles of normal and diseased tissues can be compared systemically and comprehensively. Subsequent bioinformatics (in silico) analysis allows identification of important molecular networks from available genome-wide data, leading to identification of novel disease mechanisms and new biomarkers with potential clinical applications.
We conducted a 2-step study in which we performed transcriptome analysis that was followed by in silico gene expression analysis and then in vitro analysis to identify key molecules driving the development of aortic dissection.
METHODS

Patients, aortic specimens and study design
Potential study patients were 25 patients who underwent aortic repair for ATAAD at Saitama Medical Centre, Jichi Medical University, Saitama, Japan., between September 2013 and January 2015. The ATAAD was diagnosed by means of contrastenhanced computed tomography, and aortic repair was performed within 48 h of symptom onset in all 25 patients. Aortic specimens were obtained intraoperatively from these 25 patients.
The investigation involved 2 study groups: a group of ATAAD patients and a group of transplant donors. We established a homogeneous ATAAD study group by including only those patients who met the following criteria: tricuspid aortic valve, DeBakey type I aortic dissection, patent false lumen, no intimal calcification, no family history of thoracic aortic disease, no previous history of inflammatory aortic disease and no extracardiovascular manifestations of syndromic connective tissue disease. Eight of the 25 patients met the above noted criteria, and these 8 patients (7 men, 1 woman; mean age, 54.4 years) made up our ATAAD study group. Our transplant study group was a control group made up of 9 transplant donors (6 men, 3 women; mean age, 39.0 years).
Specimens of aortic tissue were obtained from both study groups. The aortic dissection of all ATAAD patients extended along the entire ascending aorta, and all specimens of dissected aorta were obtained intraoperatively from the mid-portion of the ascending aorta. These specimens were 1.5-2.0 cm in diameter. None of the specimens collected were of intact aorta. Specimens obtained from the control group were also 1.5-2.0 cm in diameter and from the mid-portion of the ascending aorta.
The 2-step study approach is diagrammed in Fig. 1 . For gene expression profiling, gene expression analysis was performed by means of mRNA and microRNA (miRNA) microarrays. Quality and abundance of the extracted RNA samples were evaluated with an RNA 6000 Nano Kit on a 2100 Bioanalyzer (Agilent Step 1: Gene expression profiling. mRNA and miRNA microarrays analyses were performed on aortic specimens obtained from 5 of the 9 transplant donors (control group, n = 5) and 6 of the 8 ATAAD patients. RNA integrity numbers of these specimens were >6.5. From among differentially-expressed (DE) genes, target genes were identified by gene ontology analysis. A search of the literature allowed us to identify target miRNA related to the target genes (asterisk). Validation quantitative polymerase chain reaction (qPCR) was performed for the DE genes and miRNA in samples obtained from all transplant donors (n = 9) and all ATAAD patients (n = 8) (asterisk). Ingenuity Pathway Analysis (IPA) identified cytokines that function upstream of the target genes.
Step 2: In vitro assessment. HAECs and AoSMCs were stimulated by the upstream cytokines. Expression of target genes and of target miRNA was assessed in cultured cells by qPCR. ATAAD: acute type A aortic dissection; HAECs: human aortic endothelial cells; AoSMCs: human aortic smooth muscle cells.
Technologies, Santa Clara, CA, USA). Eleven samples (6 individual ATAAD samples and 5 individual transplant donor samples) with initial RNA integrity numbers >6.5 were used for the gene expression profiling. In silico gene expression analysis was performed to determine target genes and related miRNA. Quantitative polymerase chain reaction (qPCR) was performed to validate the microarray results, and the total 17 samples from the 2 study groups were used for qPCR because the RNA integrity numbers of the 6 samples that were not used in the microarray analyses had improved to >6.5 upon the second RNA extraction. The data were analysed with ingenuity pathway analysis (IPA) (ingenuity systems, www.ingenuity.com) to identify the upstream cytokines driving expression of the target genes. In step 2 (in vitro assessment), the expression of target genes and of miRNA in human aortic endothelial cells (HAECs) and aortic vascular smooth muscle cells (AoSMCs) was measured by means of qPCR after stimulation by identified upstream cytokines.
Upon collection of the tissue specimens, blood or blot clots that were attached were removed. The adventitial and intimamedia layers of the specimens were immediately separated and then snap-frozen with liquid nitrogen. Frozen samples were stored at -80 C until RNA isolation. Patients' clinical information, including their medical history and comorbidities, was obtained from hospital records. The study was approved by the Institutional Review Boards of Saitama Medical Center, Jichi Medical University, Saitama, Japan; Stanford University School of Medicine, Stanford, CA, USA, and the National Center for Child Health and Development, Tokyo, Japan. All patients gave written informed consent for the specimen collection and use of their anonymized clinical information.
Cell culture and reagent, RNA isolation and quantitative polymerase chain reaction
The detailed information is shown in the Supplementary Material.
Microarray experiments and data analysis
Microarray analysis of specimens obtained from 6 ATAAD patients and 5 transplant donors was performed with human mRNA Microarray Kit c and human miRNA Microarray Kit (8 Â 60 K, Agilent Technologies) to screen for mRNAs and miRNAs, respectively. One aortic intima-media tissue sample of 1.5-2.0 cm in diameter was used in the microarray experiments.
Data analysis was performed with GeneSpring 12.5 (Agilent Technologies). To adjust for variation in the staining intensity between microarrays, the expression levels of all genes on a given microarray chip were normalized by dividing the measurement by the 75th percentile of all measurements on that microarray. Quality control was achieved with the Filter Probe sets by Flags tool, and, as a result, 32 425 of 42 545 probes (mRNA) and 405 of 1368 probes (miRNA) were used for further analyses. mRNAs or miRNAs showing significant signal intensity (>2.0-fold, adjusted P < 0.05, Mann-Whitney U-test with Benjamini-Hochberg false discovery rate correction) were determined to be differentially expressed (up-or down-regulated). The false discovery rate is a comparison of the number of times that the real data has a certain P-value versus the number of times that randomized data has the same or better P-value, thereby addressing the multiple comparisons problem that occurs when calculating P-values for hundreds or thousands of categories, and protects against overinterpreting P-values that do not have biological meaning [12] . Hierarchical clustering was performed on the basis of the gene expression data. The differentially expressed genes were subjected to gene ontology analysis (GOA) performed with the NextBio search engine (http://www.nextbio.com/b/nextbio.nb), and target genes were then determined from the top 15 related pathways. Of the differentially expressed miRNAs, target miRNAs that interact with target genes were determined by a search of the literature.
To further investigate the global molecular network, especially to identify upstream cytokines in pathological signalling cascades, the target genes were imported into IPA (version 27821452) [13] .
Statistical analyses
Values are presented as mean ± SD, median (interquartile range), or percentages, as appropriate. Between-group differences were analysed by Mann-Whitney U-test or analysis of variance (ANOVA) with Bonferroni correction for multiple comparisons. P < 0.05 was considered statistically significant. All statistical analyses were performed with KaleidaGraph version 4.0 (Synergy Software, Reading, PA, USA).
RESULTS
Characteristics of the ATAAD patients and transplant donors
Patient information is shown in Supplementary Material, Table  S2 . The microarray analysis was performed on specimens from 6 ATAAD patients and 5 transplant donors. Age (ATAAD group, 54.2 ± 5.8 years; control group, 45.4 ± 9.2 years; P = 0.086) and prevalence of male sex (ATAAD group, 100% (6/6); transplant donor group, 60% (3/5); P = 0.36) did not differ significantly. Validation qPCR was performed in specimens obtained from all 8 ATAAD patients and form all 9 transplant donors. The ATAAD patients were older than the transplant donors (54.4 ± 8.0 years vs 39.0 ± 13.1 years, respectively; P = 0.012), but the prevalence of male sex did not differ between the 2 groups (88% (7/8) vs 67% (6/9), respectively; P = 0.67).
mRNA microarray analysis
The mRNA microarray gene profiling revealed 1536 genes (3.6%, 1536/42 545 probes) that were significantly differentially expressed in the ATAAD group. These 1536 genes were visualized as a heat map, shown in Supplementary Material, Fig. S1 , after non-biased hierarchical cluster analysis. Of the 1536 genes, 319 were up-regulated, and 1217 were down-regulated. The top 50 significantly up-and down-regulated genes are shown in Supplementary Material , Table S3 .
The top 15 related pathways identified by GOA and differentially expressed genes are shown in Table 1 . These 15 pathways included ECM, regulation of inflammatory response, cell surface, and growth factor activity. Based on the GOA results, we pickedup 7 additional target genes from the 1536 differentially expressed genes ( Table 2 ). The 7 target genes included JAK2 (regulation of inflammatory response), PDGFA, TGFB1, VEGFA (growth factor activity) and TIMP3, TIMP4, SERPINE1 (ECM). The significantly up-and down-regulated genes related to MMP regulation are shown in Supplementary Material, Table S4 .
Validation quantitative polymerase chain reaction
To validate the gene expression profiles obtained via mRNA microarray analysis, we assessed and compared expression of the above-mentioned 7 target genes detected by applying SYBR Green qPCR to aortic specimens obtained from the 8 ATAAD patients and the 9 transplant donors. All 7 genes were shown to be significantly up-or down-regulated in the ATAAD group (Fig. 2) .
Ingenuity pathway analysis of the mRNA microarray data plus in vitro experimentation
To identify cytokines regulating transcription of the target genes in silico, upstream analysis was performed with IPA. The predictions were conducted based on the activation z-score and P-value of overlap generated from literature-based data stored in the ingenuity knowledge base. IPA identified TNF-a and TGF-b as the upstream cytokines driving expression of target genes in the disease cascades (Table 3) .
To confirm the IPA findings, we treated HAECs and AoSMCs with recombinant TNF-a and TGF-b, and we followed this with qPCR assay of TIMP3, VEGFA, and JAK2 at different time points. In AoSMCs, 48-h stimulation with both TNF-a and TGF-b significantly down-regulated TIMP3 expression. In addition, stimulation with TNF-a alone down-regulated TIMP3 expression at both 24 h and 48 h. Stimulation with TGF-b alone and with both TNF-a and TGF-b significantly increased VEGFA at 6 h but not at 24 h (Fig. 3 ). TIMP3 and VEGFA were mildly expressed in HAECs at all time points, and adding the cytokines did not increase the expression levels (Fig. 3 ). There were no significant differences in Table S5 ). miR-29, a miRNA reported to be involved in the pathogenesis of aortic disease [14, 15] , was not differentially expressed between the groups. Of the 41 differentially expressed miRNAs, we focused on miR-21-5p, knowing that miR-21 down-regulates TIMP3 expression during the process of cardiac fibrosis [16] . To elucidate the involvement of miR-21-5p in the development of aortic dissection, we applied qPCR to aortic specimens. miR-21-5p expression was up-regulated in the ATAAD patient group (Fig. 4A) . To further investigate miR-21-5p expression in AoSMCs, we performed in vitro experiments using the afore-mentioned upstream cytokines. Twenty-four hour-stimulation with both TNF-a and TGF-b increased miR-21-5p expression in AoSMCs (fold change: 1.36; Fig. 4B ), suggesting that TNF-a and TGF-b stimulation downregulates TIMP3 expression, partially through increased miR-21-5p expression in AoSMCs.
DISCUSSION
Microarray analysis has been used previously to compare gene expression profiles between patients with and without aortic dissection [8] [9] [10] ; however, none of the studies validated the microarray results through other in vivo or in vitro systems. Adding in vitro study to gene expression profiling can provide for detailed elucidation of pathological mechanisms at the cellular level, and this experimental approach has been used effectively to answer questions pertaining to cardiovascular disease [11] . To the best of our knowledge, this is the first study to combine gene expression profiling with in vitro study for investigation of the pathogenesis of aortic dissection.
We identified the 7 target genes by GOA. These included JAK2, PDGFA, TGFB1, VEGFA, TIMP3, TIMP4 and SERPINE1. IPA showed TNF-a and TGF-b may regulate expression of the target genes, and in vitro experiments suggested down-regulation of target gene TIMP3 and up-regulation of target gene VEGFA were due to the regulatory effects of TNF-a and TGF-b on VSMCs. Furthermore, expression of miR-21-5p, a TIMP3 repressor, was increased in the aortic specimens of the ATAAD patients and in AoSMCs stimulated with TNF-a and TGF-b, suggesting that TIMP3 down-regulation may be due in part to increased miR-21-5p expression. Increased expression of metalloproteinases (MMPs), a family of proteolytic enzymes that degrade various components of the ECM, has been recently observed in the aorta [8, 10, 17] and blood [18] of patients with aortic dissection. MMPs are regulated at various levels, including that of gene expression, pro-MMP secretion from producing cells, extracellular localization, and enzyme inhibition by the naturally present TIMPs [19, 20] . Consistent with this theory, various MMP related genes were shown by our microarray study to be differentially expressed (Supplementary Material, Table  S4 ). Nevertheless, it remains unclear whether MMP activation precedes the dissection or MMP up-regulation occurs in response to the local trauma caused by the dissection [20] . In most previous studies, MMP expression was measured only locally in the harvested aortic specimens [8, 10, 17] . We observed decreased expression of both TIMP3 and TIMP4 in the aortic specimens from our ATAAD patients. In addition, TIMP3 expression was decreased in AoSMCs under stimulation by TNF-a and TGF-b. Thus, MMP-TIMP dysregulation may play a role in pre-dissection medial degeneration. Kunihara et al. reported, upon study of an angiotensin II infusion mouse model of aortic dissection, that MMP 9 produced by infiltrating neutrophils can trigger aortic dissection [18] . Future studies will be needed to determine the detailed mechanisms of MMP-TIMP dysregulation.
JAK tyrosine kinases (JAK 1-3, TYK2) have pleiotropic regulatory effects and mediate signalling of 60 cytokines and hormones [21] . The biological functions of JAKs are determined by their interaction with specific cytokine receptors, and JAK2 mutation plays a critical role in the development of hematologic disorders [22] . Regarding the role of JAK2 in vascular disease, Pan et al. presumed that decreased JAK2 expression may cause overexpression of various cytokine receptors and magnified extracellular signals, leading to chronic inflammation in the aortic wall [9] . Consistent with this theory, JAK2 expression was decreased in the aortic specimens from our ATAAD patients. However, JAK2 was not up-or down-regulated in aortic cells under stimulation of the cytokines identified by IPA, suggesting that JAK2 expression is regulated by other molecular networks in the pathologic cascades.
Recently, miRNAs have been investigated as regulators of various cardiovascular systems. miR-29 is known to play a fundamental role in the development of aortic aneurysm by altering TGF-b signalling in VSMCs [14, 15] . We showed in Marfan syndrome mice (Fb1 C1039G/-) that miR-29 b inhibition prevents early aneurysm formation and aortic wall apoptosis [23] . However, the current study failed to show altered miR-29 expression in the ATAAD group. Instead of miR-29, we focused on miR-21-5p from the 41 differentially expressed miRNAs. miR-21 regulates the ERK-MAP kinase signalling pathway in cardiac fibroblasts and its up-regulation induces cardiac fibrosis [24] . In addition to this important cardiac remodelling effect, miR-21 reportedly modulates apoptosis of endothelial cells [25] and VSMCs [26] . Recently, Zhang et al. reported, in myocardial infarction, TNF-a, TGF-b, and IL-6 activate several biological pathways, including JAK and OI3K/AKT pathways. These signal transduction pathways activate transcription factors, including STAT3 and SP1, to promote transcription of miR-21-5p, TIMP3, and VEGFA, resulting in cardiac fibrosis and apoptosis [16] . We hypothesize preceding activation of similar biological pathways in the predissection aortic media in patients without a connective tissue disorder, causing chronic inflammation predisposing to aortic dissection. The predicted molecular network is shown in Fig. 5 . In the pre-dissection aortic media, TNF-a and TGF-b may upregulated in response to physical or physiological factors. Upregulation of these cytokines may influence MMP homeostasis, including MMP-TIMP balance, and promote PDGFA and VEGFA activation, via several biological pathways. TGF-b may upregulate miR-21-5p, resulting in down-regulation of TIMP3 transcription, causing MMP-TIMP dysregulation.
Limitations
There are several limitations in this study. First, the sample size was smaller than optimal. Future large-scale study is needed. Second, the number of female patients in the ATAAD group was small, so none were included in the microarray study, and only 1 was included in the validation qPCR. Furthermore, although the age difference of patients included in the microarray studies was not significant, patients in the ATAAD group were older, on average, than patients in the control group. Such age and sex differences could have influenced results of the experiments. Lastly, we did not perform in vivo experiments to confirm the biological importance of the identified target molecules. The molecular network we identified may reflect the disease cascade only in part. Future in vivo experiments involving target gene-deficient animals are needed to expand upon our study findings.
CONCLUSION
We applied a novel experimental approach by integrating in vitro assessment into gene expression profiling of aortic dissection. Our results implicate chronic inflammation characterized by MMP-TIMP dysregulation, increased TGF-b signalling, and VEGFA up-regulation in development of the disease condition. TIMP3 down-regulation may be caused by the regulatory effects of TNF-a and TGF-b on VSMCs, and miR-21-5p might be involved in the development of aortic dissection via this TIMP3 down-regulation.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online. 
